Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Alkem Laboratories Ltd Financial Statements & Historical Data

Updated NSE: ALKEMBSE: 539523
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 8:06 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price5,220₹ per share
Reported P/E27.5Times
Book value per share1,156₹ per share
Reported ROCE21.2 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 8:06 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap62,413 Cr.
Current Price5,220
High / Low5,934/5,051
Stock P/E27.5
Book Value1,156
Dividend Yield1.02 %
ROCE21.2 %
ROE18.9 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Alkem Laboratories Ltd 62,413 Cr. 5,220 5,934/5,05127.5 1,1561.02 %21.2 %18.9 % 2.00
Biocon Ltd 60,413 Cr. 371 447/33883.1 2100.13 %3.61 %1.40 % 5.00
Glenmark Life Sciences Ltd 65,787 Cr. 2,331 2,538/1,79321.1 3720.21 %39.8 %23.6 % 1.00
Glenmark Pharmaceuticals Ltd 65,787 Cr. 2,331 2,538/1,79321.1 3720.21 %39.8 %23.6 % 1.00
Abbott India Ltd 57,035 Cr. 26,840 30,655/25,13535.3 2,2471.96 %44.8 %34.4 % 10.0
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Alkem Laboratories Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 2,9683,4403,3242,9363,0323,4153,3743,1443,3714,0013,7373,6033,740
Expenses 2,5792,6932,6162,5342,4232,6622,6152,7522,6323,0802,9093,0862,974
Operating Profit 389747708402609753759391739921828517766
OPM % 13%22%21%14%20%22%23%12%22%23%22%14%20%
Other Income 6664276120134931461491049065153
Interest 30302527292836283035425447
Depreciation 72747083807985112889495106100
Profit before tax 353648655367619780731396771896781423772
Tax % 18%5%8%17%11%10%12%18%13%13%16%40%32%
Net Profit 288615604304550702641322668779653251521
EPS in Rs 23.9851.9049.7624.5545.6057.6052.3425.5855.5663.9953.1919.7843.49

Last Updated: September 30, 2026, 12:38 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 10:08 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3,1133,6744,9055,6886,4017,3578,3448,86510,63411,59912,66812,96514,71215,081
Expenses 2,7003,2484,0384,6875,3926,2376,8686,9208,5809,97710,41910,45211,70612,049
Operating Profit 4134278661,0011,0091,1201,4761,9452,0541,6222,2492,5123,0073,032
OPM % 13%12%18%18%16%15%18%22%19%14%18%19%20%20%
Other Income 16217622711011582102230146101186494407412
Interest 938171455555655952107112122161178
Depreciation 527193101143193253275304310299357382395
Profit before tax 4304519289659269551,2601,8421,8441,3052,0232,5272,8712,872
Tax % -1%13%19%6%31%19%9%12%9%23%10%12%18%
Net Profit 4353927529056387741,1491,6181,6801,0071,8112,2152,3512,204
EPS in Rs 364.1032.7562.0274.6152.7763.6194.26132.57137.6382.31150.19181.11192.51180.45
Dividend Payout % 5%12%20%20%25%25%27%23%25%61%27%25%28%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-9.89%91.84%20.35%-29.50%21.32%48.45%40.82%3.83%-40.06%79.84%22.31%6.14%
Change in YoY Net Profit Growth (%)0.00%101.72%-71.49%-49.85%50.82%27.13%-7.63%-36.99%-43.89%119.90%-57.53%-16.17%

Alkem Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:9%
3 Years:7%
TTM:4%
Compounded Profit Growth
10 Years:20%
5 Years:14%
3 Years:9%
TTM:6%
Stock Price CAGR
10 Years:Not available
5 Years:14%
3 Years:20%
1 Year:-15%
Return on Equity
10 Years:19%
5 Years:19%
3 Years:17%
Last Year:19%

Last Updated: September 4, 2025, 10:45 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 27, 2026, 4:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 242424242424242424242424
Reserves 2,9753,6684,4444,8405,4156,1377,3538,6149,02110,28811,96113,796
Borrowings 1,3066586599989441,6161,7072,6681,3971,4181,3812,047
Other Liabilities 9861,1841,4401,8031,8242,1692,4352,7633,3153,8444,3254,991
Total Liabilities 5,2915,5346,5687,6648,2089,94611,51914,06913,75715,57517,69120,858
Fixed Assets 1,3741,4501,7972,2842,5302,9082,7932,9022,6832,8732,8523,871
CWIP 111172299381493363393339323159548282
Investments 4815095534443242613333716224841,8461,869
Other Assets 3,3253,4033,9184,5554,8616,4138,00010,45710,12912,06012,44514,836
Total Assets 5,2915,5346,5687,6648,2089,94611,51914,06913,75715,57517,69120,858
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 3257264712667805851,2651,1111,6821,9481,9131,963
Cash from Investing Activity + -235205-294-351-318-737-995-1,433120-1,011-1,288-1,682
Cash from Financing Activity + -52-927-13885-37979-272380-1,761-1,145-811-503
Net Cash Flow 39340082-73-25842-207-186-222
Free Cash Flow 190472-163-4112532371,1167831,4531,7611,2781,476
CFO/OP 101%107%73%47%92%59%86%73%121%105%96%86%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow190.00472.00-163.00-411.00253.00237.001,116.00783.001,453.001,761.001,278.001,476.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 435242466262726665676569
Inventory Days 163169169198221186198241262194197224
Days Payable 8110110812214711910411210287129141
Cash Conversion Cycle 126121103122135129167196225174132152
Working Capital Days -26-521334405544473166135124
ROCE %14%12%23%21%17%16%18%22%18%14%20%20%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 56.74%56.74%56.74%56.38%55.66%55.66%55.13%53.04%51.20%51.20%51.20%49.70%
FIIs 6.03%8.49%9.11%8.69%9.02%10.14%9.40%9.11%9.47%9.97%10.15%10.42%
DIIs 17.63%15.91%15.63%18.56%19.21%18.01%19.42%21.80%21.93%21.54%21.39%22.64%
Public 19.58%18.86%18.51%16.37%16.12%16.19%16.05%16.05%17.39%17.30%17.25%17.25%
No. of Shareholders 69,44265,18465,83069,62774,74484,03884,32679,74067,19664,53662,83562,822
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid Cap Fund 2,601,633 1.6 1477.081,802,9782026-02-23 07:04:3544.3%
SBI Large & Midcap Fund 1,476,712 2.24 838.4N/AN/AN/A
ICICI Prudential Multi Asset Fund 1,289,672 0.91 732.211,450,0722026-02-23 07:04:35-11.06%
Nippon India Growth Mid Cap Fund 1,163,397 1.58 660.52N/AN/AN/A
SBI Contra Fund 1,004,007 1.17 570.03452,4002025-12-07 15:45:16121.93%
ICICI Prudential Large & Mid Cap Fund 968,758 2 550.011,121,7972026-02-23 07:04:35-13.64%
DSP Mid Cap Fund 748,010 2.23 424.681,566,4212025-12-07 16:59:56-52.25%
SBI Midcap Fund 685,892 1.74 389.42N/AN/AN/A
DSP Large & Mid Cap Fund 440,106 1.43 249.87N/AN/AN/A
Nippon India Multi Cap Fund 418,576 0.49 237.65N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 181.11150.1982.31137.63132.57
Diluted EPS (Rs.) 181.11150.1982.31137.63132.57
Cash EPS (Rs.) 215.24176.56110.18165.98158.29
Book Value[Excl.RevalReserv]/Share (Rs.) 1002.50896.23789.21740.05632.20
Book Value[Incl.RevalReserv]/Share (Rs.) 1002.50896.23789.21740.05632.20
Revenue From Operations / Share (Rs.) 1084.441059.61970.24889.52741.53
PBDIT / Share (Rs.) 251.43213.83152.70185.33181.98
PBIT / Share (Rs.) 221.56188.79126.73159.90159.01
PBT / Share (Rs.) 211.38169.23109.14154.27154.09
Net Profit / Share (Rs.) 185.36151.5284.22140.55135.32
NP After MI And SOA / Share (Rs.) 181.14150.2182.32137.65132.58
PBDIT Margin (%) 23.1820.1815.7320.8324.54
PBIT Margin (%) 20.4317.8113.0617.9721.44
PBT Margin (%) 19.4915.9711.2417.3420.77
Net Profit Margin (%) 17.0914.298.6715.8018.24
NP After MI And SOA Margin (%) 16.7014.178.4815.4717.87
Return on Networth / Equity (%) 18.0617.4110.8819.0521.48
Return on Capital Employeed (%) 19.2919.4915.0720.6324.01
Return On Assets (%) 12.2411.527.1511.6913.75
Long Term Debt / Equity (X) 0.020.000.000.000.00
Total Debt / Equity (X) 0.080.110.140.290.22
Asset Turnover Ratio (%) 0.770.860.830.710.69
Current Ratio (X) 2.762.612.351.761.92
Quick Ratio (X) 2.021.941.651.131.28
Inventory Turnover Ratio (X) 4.641.251.091.331.23
Dividend Payout Ratio (NP) (%) 23.1829.9653.450.0021.12
Dividend Payout Ratio (CP) (%) 19.9025.6840.630.0018.00
Earning Retention Ratio (%) 76.8270.0446.550.0078.88
Cash Earning Retention Ratio (%) 80.1074.3259.370.0082.00
Interest Coverage Ratio (X) 24.7022.7417.0042.3136.92
Interest Coverage Ratio (Post Tax) (X) 19.2118.2011.3433.3728.46
Enterprise Value (Cr.) 58288.8759097.0539701.2743453.4033002.69
EV / Net Operating Revenue (X) 4.504.673.424.093.72
EV / EBITDA (X) 19.3923.1221.7519.6115.17
MarketCap / Net Operating Revenue (X) 4.504.663.504.073.74
Retention Ratios (%) 76.8170.0346.540.0078.87
Price / BV (X) 4.875.734.495.014.49
Price / Net Operating Revenue (X) 4.504.663.504.073.74
EarningsYield 0.030.030.020.030.04
Advertisements
Explore Industry-wise Company financial data